Tilray CEO on shares being down, oversupply, U.S. cannabis regulation and Canada expansion plans
Irwin Simon, Tilray CEO, joins ‘Closing Bell’ to discuss the firm’s shares being down over the final 365 days and what headwinds the firm is facing.
Tilray CEO: Opportunities in clinical cannabis are substantial
Tilray’s stock is up as of late, nonetheless level-headed down 80 percent from a February high. CNBC’s Frank Holland reports on his dialog with Tilray CEO Irwin Simon about the…
Tilray shares pop on solid fourth quarter earnings
Tilray CEO Irwin Simon is bullish on his company’s situation in the cannabis industry. The corporate exceeded earnings estimates and is seeing a upward push in its piece mark. For…
Hashish shares pop as Congress votes on weed legislation
Tilray CEO Irwin Simon weighs in on the congressional push for new cannabis felony pointers on ‘The Claman Countdown.’Subscribe to Fox Enterprise! eWatch extra Fox Enterprise Video: mWatch Fox Enterprise…
Tilray CEO: There’s a potential to grow the business by infusing whiskey with cannabis
Irwin Simon, Tilray CEO, joins ‘Closing Bell’ to discuss its acquisition of Breckenridge distillery, and the possibility of infusing whiskey with cannabis. For access to live and exclusive video from…